Insys Therapeutics Inc. (fka INSYQ)

[terry hallinan]

Most odd. Unusual realism inside a wild pump for a probable nothing-burger:

Insys Therapeutics (NASDAQ:INSY) is generally known as a “marijuana stock” but it would be a bit of a misnomer to lump this company in with pot stocks. Insys’ main product is a sublingual pain medication known as Subsys. However, using the same proprietary sublingual spray technology and their advanced knowledge of synthetic cannabinoids, the company is at the forefront of a new pharmaceutical movement.

Founded in 1990, Insys has been around the block. The company clearly has staying power and investors have taken note. With a market cap of nearly $700M, Insys is a promising investment for those interested in dipping their toes into the marijuana realm.

Geez, not even a blast from the fast-fading past deviltry.

Original analysis indeed.

Link to original sickening super pump for completeness only:

https://tinyurl.com/ycufu5wb

Best, Terry